Alexandria Real Estate Equities, Inc. (ARE) has a MoatMap StockRank of 49/100 based on Quality (36/100), Value (59/100), and Momentum (41/100) factor scores. The current signal is HOLD. Alexandria Real Estate Equities is a life science REIT facing headwinds from rising interest rates and oversupply in laboratory office spaces, failing our asset-light quality test.
Alexandria Real Estate Equities, Inc. is a specialized REIT focused on owning, operating, and developing collaborative life science and technology campuses in AAA urban innovation clusters. Its competitive moat stems from niche market leadership in high-demand life science properties, strong relationships with leading biopharma and tech tenants, and development expertise. Alexandria is the pioneer and dominant player in the life science real estate sector, strategically concentrated in key innovation hubs.
| Price | $52.95 |
| Market Cap | $8.7B |
| P/E (Forward) | -60.36 |
| Price/Book | 0.58 |
| Return on Equity | -4.1% |
| Return on Invested Capital | -3.1% |
| Debt/Equity | 66.51 |
| Gross Margin | 68.6% |
| Operating Margin | 15.9% |
| Revenue Growth | -11.5% |
| Dividend Yield | 5.4% |
| Free Cash Flow | $1.4B |
Alexandria Real Estate Equities, Inc. operates in the REIT - Office industry, part of the Real Estate sector (United States).